Navigation Links
Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes

SAN DIEGO, July 8 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today that Dr. Marcus Hompesch, the company's President and CEO, will serve as San Diego's 2010 Corporate Chairman for Step Out: Walk to Fight Diabetes, the American Diabetes Association's (ADA) largest fund-raising event.

Dr. Hompesch will help host the annual corporate community kick-off breakfast today at The University Club Atop Symphony Towers, where community and business leaders are invited to learn more about supporting the Step Out: Walk to Fight Diabetes in San Diego through corporate donations or by forming a team of walkers for the event.

The ADA's Step Out: Walk to Fight Diabetes raises about $20 million annually on a national level with more than 150 walks taking place in over 100 U.S. markets.  Step Out: Walk to Fight Diabetes in San Diego will take place Sunday, October 24 at De Anza Cove on Mission Bay.

"The event itself is truly inspirational when witnessing so many people and businesses unite together for a cause as vitally important as preventing this disease and raising funds for a cure," said Dr. Hompesch.  "For that reason, Profil Institute is proud to be teaming up with the ADA in the fight against diabetes and for its Step Out: Walk to Fight Diabetes fund-raising event in San Diego."  

About Profil™ Institute for Clinical Research, Inc.

Profil is a privately held institute providing high quality early phase clinical research services in diabetes and obesity. To date, the company has been involved with almost every clinically promising drug and device development in diabetes and in more than 120 clinical studies since its inception in 2004. Profil uses its expertise to guide the developmental planning, design and actual performance of early phase clinical studies that help in the determination of whether a new compound should be carried forward into the later phases of clinical development. The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Düsseldorf, Columbia University, University of Michigan and Harvard University.

For more information visit

About American Diabetes Association

The ADA is the nation's leading non-profit charity providing diabetes research, information and advocacy.  Each year, hundreds of thousands of people participate in ADA fund-raising events across the country to increase awareness and raise millions of dollars in the fight against this disease. Founded in 1940, the Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes.

For more information about corporate support or registering a team for San Diego's Step Out: Walk to Fight Diabetes, please contact Janell McCrensky, or 619.234.9897 x 7433.

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. ALS TDI Completes Gene Expression Profile of Lou Gehrigs Disease in Mice
5. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
6. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
7. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. Thomson Healthcare Cancer Profiler Used in Study
Post Your Comments:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):